Related Experiment Video
Updated: Aug 5, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lipids and Lipid-Lowering Drugs With Risk of Intervertebral Disc Degeneration: A Mendelian Randomization Study
1Department of Spine Surgery, Ningbo No. 6 Hospital, 1059 East Zhongshan Road, Ningbo Zhejiang, 315000, China, nbdlyy.com.
Elevated high-density lipoprotein cholesterol (HDL-C) may protect against intervertebral disc degeneration (IVDD). Lipid pathways, including NPC1L1 gene expression, show potential links to IVDD, warranting further research.
Area of Science:
- Genetics
- Metabolic Disorders
- Musculoskeletal Diseases
Background:
- Intervertebral disc degeneration (IVDD) is a significant cause of low back pain.
- The role of circulating lipid traits and their associated drug targets in IVDD pathogenesis remains unclear.
Purpose of the Study:
- To investigate the causal relationship between genetically predicted lipid traits and lipid-lowering drug targets with IVDD risk.
- To explore the influence of body mass index (BMI) on these associations.
Main Methods:
- Utilized a Mendelian randomization (MR) framework with summary-level data from genome-wide association studies (GWASs).
- Analyzed associations between lipid parameters (HDL-C, LDL-C, TG) and apolipoproteins (Apoa-I, Apob) with IVDD.
- Performed multivariable MR adjusting for BMI and drug-target MR focusing on NPC1L1.
Main Results:
- Inherently elevated high-density lipoprotein cholesterol (HDL-C) was associated with reduced IVDD susceptibility.
- This protective effect of HDL-C remained significant after adjusting for BMI.
- Low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), apolipoprotein A-I (Apoa-I), and apolipoprotein B (Apob) showed no significant association with IVDD after correction.
- NPC1L1 gene expression was significantly associated with increased IVDD susceptibility.
Conclusions:
- Circulating HDL-C may play a protective role in intervertebral disc degeneration.
- Lipid metabolism pathways, particularly those involving NPC1L1, are implicated in IVDD.
- Further investigation into lipid pathways for IVDD prevention and treatment is warranted.
Related Concept Videos
Degenerative Disc Disease I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Herniated Intervertebral Disc l: Introduction
Degenerative Disc Disease ll: Pathophysiology
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...